A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo.
Li S, Jiang Q, Liu S, Zhang Y, Tian Y, Song C, Wang J, Zou Y, Anderson GJ, Han JY, Chang Y, Liu Y, Zhang C, Chen L, Zhou G, Nie G, Yan H, Ding B, Zhao Y.
Li S, et al. Among authors: zhou g.
Nat Biotechnol. 2018 Mar;36(3):258-264. doi: 10.1038/nbt.4071. Epub 2018 Feb 12.
Nat Biotechnol. 2018.
PMID: 29431737